Haemato AG (HAEK) — Working Capital to Net Assets Ratio

Latest as of December 2022: 28.9%

Haemato AG (HAEK) has a Working Capital to Net Assets ratio of 28.9% as of December 2022. Working capital of €42.50 Million (current assets of €69.27 Million minus current liabilities of €26.77 Million) is measured against net assets of €147.17 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Haemato AG (HAEK) balance sheet quality index to measure how much of total assets are equity-financed.

WC/NA Ratio

28.9%
Working Capital / Net Assets

Working Capital

€42.50 Million
EUR

Current Assets

€69.27 Million
EUR

Current Liabilities

€26.77 Million
EUR

Haemato AG Working Capital to Net Assets (2021–2022)

This chart shows how Haemato AG's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the ratio stands at 28.9%, reflecting working capital of €42.50 Million against net assets of €147.17 Million EUR. Check Haemato AG (HAEK) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Haemato AG (2021–2022)

The table below presents the year-by-year Working Capital to Net Assets ratio for Haemato AG from 2021 to 2022, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Haemato AG (HAEK) market capitalisation.

Year WC/NA Ratio Working Capital (EUR) Net Assets Current Assets Current Liabilities Change (pp)
2022 28.9% €42.50 Million €147.17 Million €69.27 Million €26.77 Million ▼ -1.5 pp
2021 30.4% €43.98 Million €144.73 Million €81.07 Million €37.09 Million
pp = percentage points